Federal officials added Hawaii to a ten‑state Medicaid demonstration to expand mental‑health and addiction care. Maui clinics are slated for early certification.

A national firefighter cancer registry is growing quickly, but Nevada signups lag. Local experts say bigger enrollment is needed to link southern Nevada exposures to long‑term risk.

A CDC review of consultations from 2014–2024 links about 145 U.S. patients to post‑op infections and four deaths after cosmetic surgery travel, prompting calls for stronger monitoring and patient guidance.

The FDA approved Xocova, the first oral pill to prevent COVID after exposure, for people 12 and older. A Phase 3 trial found a 67% drop in symptomatic infection.

Two D.C. families say their infants were secretly enrolled in a 1960s NIH‑backed RSV trial and later died; lawyers allege preserved tissue informed 2023 vaccine research.

HHS Secretary Robert F. Kennedy Jr. will outline federal steps to improve Lyme testing and care in Concord on May 29, 2026. The package includes investments in diagnostics and a renewed LymeX accelerator.

Federal data show 31 children died in 2025 after being left in hot vehicles. Sevierville police echoed prevention tips urging drivers to check back seats and lock cars.

FDA testing found sildenafil in Boner Bears Sex Chocolate; JXK Enterprises recalled Lot BB21125 and is offering refunds. Buyers should stop use and report problems.

A limited number of SkinnyDipped Dark Chocolate Coconut Almond Bites were recalled after undeclared peanuts were found in individual wrappers. No illnesses were reported as of the notice.

A WalletHub study finds Alaska, Oregon and Maine spend the largest share of household income on routine medical care as out‑of‑pocket costs climb.

CVS Caremark will add Eli Lilly’s Zepbound back to some commercial formularies on Oct. 1, 2026, reversing a mid‑2025 exclusion that limited patient options.

A Utah clinic advertising $399 MRIs highlights why hospital outpatient charges can run into the thousands. Here’s what drives the gap and how patients can shop smarter.

The American Cancer Society added Guardant’s Shield blood test as a screening option for adults 45 and older, while reaffirming colonoscopy and stool tests remain best at preventing cancer.